KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Delek US Holdings (DK) Shares Issued (2022 - 2024)

Delek US Holdings has reported Shares Issued over the past 2 years, most recently at $165.7 million for Q4 2024.

For Q4 2024, Shares Issued changed N/A year-over-year to $165.7 million; the TTM value through Sep 2025 reached $165.7 million, up 25.34%, while the annual FY2024 figure was $297.9 million, N/A changed from the prior year.
Shares Issued for Q4 2024 was $165.7 million at Delek US Holdings, up from -$100000.0 in the prior quarter.
Over five years, Shares Issued peaked at $165.7 million in Q4 2024 and troughed at -$13.3 million in Q4 2022.